Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06774300Recruiting
Video-based alcohol help for college students
This study tests whether a brief alcohol check-in and advice session, done over video call, works well for college students. It aims to help students who binge drink and want to cut down or avoid more drinking-related problems.
Houston, TexasAges 18–26 - NCT06776848RecruitingPhase 1/Phase 2
Lithium for TBR1-related neurodevelopmental disorder
This trial tests whether taking lithium for 2 years can improve symptoms in people with a TBR1 gene change that causes neurodevelopmental challenges. It aims to see if lithium is safe and helpful for this condition.
DijonAges 6 years+ - NCT06771830Recruiting
Study of a tool that helps spot sick kids early
This study looks at a tool called pediatric eCART that helps nurses and doctors know which children in the hospital might be getting sicker. Researchers want to see if it works well to improve care.
Madison, WisconsinAges Up to 17 years - NCT06769152RecruitingPhase 2
HLX43 for advanced gynecological cancers
This trial tests a new drug, HLX43, that targets a protein called PD-L1 found on some cancer cells. It is for people with advanced cervical or ovarian cancer that has stopped responding to standard treatments.
Ji'nan, ShandongAges 18–75 - NCT06770569RecruitingPhase 1
Study of HRS-3802 for advanced solid tumors
This trial tests an experimental drug called HRS-3802 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and how the body processes it.
Saint Leonards, New South WalesAges 18 years+ - NCT06771479RecruitingPhase 1
Monkeypox vaccine safety and immune response study
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
Zhengzhou, HenanAges 18 years+ - NCT06767800RecruitingPhase 2
Study of TQB2102 with immunotherapy for HER2-positive gastroesophageal cancer
This trial tests a new combination of drugs (TQB2102, benmelstobart, and pembrolizumab) with or without chemotherapy for people with HER2-positive gastroesophageal cancer that cannot be removed by surgery or has spread. It aims to see if this combination is more effective than current treatments.
Fuyang, AnhuiAges 18–75 - NCT06763965Enrolling by invitationPhase 1/Phase 2
BioTTT001 for recurrent high-grade glioma
This trial tests a new drug called BioTTT001 for people whose high-grade brain tumor has come back after standard treatment. The drug is given through a small device placed in the head to deliver it directly to the tumor area.
Beijing, Chaoyang DistrictAges 18 years+ - NCT06769607Recruiting
New auto-CPAP algorithm for sleep apnea
This study tests a new, smarter way for your CPAP machine to automatically adjust air pressure while you sleep. If you have a ResMed AirSense 10 or 11 and have been using it for a few months, you may be eligible.
Bella Vista, New South WalesAges 18 years+ - NCT06771206Recruiting
Testing a new oxygen sensor in newborns
This study checks how well a new Owlet sensor measures oxygen levels in newborns. It is for babies who already have an arterial line in place for routine blood tests.
Birmingham, AlabamaAges birth–4 weeks - NCT06769113RecruitingPhase 2
Study of HLX43 for advanced esophageal cancer
This trial tests a new drug, HLX43, for people with advanced esophageal squamous cell carcinoma that has stopped responding to or cannot tolerate standard treatments. It aims to see if HLX43 can help shrink or control the cancer.
Jinan, ShandongAges 18–75 - NCT06765980RecruitingPhase 1/Phase 2
Study of KRIYA-825 for geographic atrophy in age-related macular degeneration
This trial tests an experimental drug called KRIYA-825 (also known as VV-14295) for people with geographic atrophy, a late stage of dry age-related macular degeneration that causes vision loss. The study aims to see if the treatment is safe and can help slow the progression of the disease.
Erie, PennsylvaniaAges 55–80 - NCT06771102Recruiting
New single-use gastroscope compared to standard for bedside use
This trial tests a single-use gastroscope used at the bedside versus the standard reusable gastroscope used in the endoscopy unit. It aims to see if the bedside scope works as well for patients who are already in the hospital and need an upper endoscopy without general anesthesia.
KøgeAges 18 years+ - NCT06760507Recruiting
Family history screening for BRCA cancers in rural clinics
This trial tests a program to help women in rural public health clinics learn about their family history of BRCA-related cancers. It aims to increase genetic screening and counseling for those at higher risk.
Atlanta, GeorgiaAges 25 years+ - NCT06762431RecruitingPhase 1/Phase 2
CAR T-cell therapy plus lenalidomide for CLL
This trial tests a combination of two treatments—CAR T-cells (your own immune cells reprogrammed to attack cancer) and lenalidomide (a pill that boosts the immune system)—for people with chronic lymphocytic leukemia (CLL) that has not responded to or returned after at least one prior treatment. It aims to see if this combination is safe and works better than either alone.
Vitebsk, Select A StateAges 18 years+ - NCT06762210Recruiting
Quit smoking with AI and dental health checks
This trial tests whether a smartphone app that uses artificial intelligence (AI) can help you quit smoking by looking at how it affects your dental health. If you smoke at least 5 cigarettes a day and want to quit, you may be able to join.
Fayoum, Alexandria GovernorateAges 21–65 - NCT06768268Enrolling by invitationPhase 1/Phase 2
Better lymph node imaging for breast cancer
This trial tests whether adding two common fluids (Mannitol and Voluven) before an ICG dye injection can help surgeons better see the lymph nodes that need to be removed during breast cancer surgery. It aims to make sentinel lymph node biopsies more accurate and safer.
Hsinchu CountyAges 20–70 - NCT06762990Enrolling by invitation
Back and hip movement during Muslim prayer
This study looks at how the spine and pelvis move during common Muslim prayer positions. It might help if you are healthy, can pray comfortably, and want to help researchers learn more.
Asyut, Asyut GovernorateAges 18–55 - NCT06766058Recruiting
Can aromatherapy reduce distress before breast cancer radiotherapy?
This trial tests if inhaling certain scents (aromatherapy) can help calm and reduce distress in breast cancer patients just before their first radiotherapy session.
SingaporeAges 21–99 - NCT06770062Recruiting
How the heart changes after mitral valve repair surgery
This study at Mayo Clinic uses MRI and other tests to see how the heart's main pumping chamber changes shape after robot-assisted mitral valve repair surgery for severe mitral regurgitation. It may help doctors better understand how patients recover.
Rochester, MinnesotaAges 18 years+ - NCT05432024Recruiting
Heart MRI checks how well ablation lesions form
This study uses a special heart MRI to look at how ablation creates scar tissue in people with atrial fibrillation. It may help doctors improve how ablation is done and understand which technique works best.
NieuwegeinAges 18 years+ - NCT06248723Recruiting
Preventing memory decline in older adults with lifestyle changes
This study tests a personalized program of lifestyle changes (diet, exercise, brain training, etc.) to see if it can prevent memory loss and keep older adults independent. You may qualify if you are 60+, have mild frailty, and have certain risk factors for dementia.
MonzaAges 60 years+ - NCT06695026RecruitingPhase 1/Phase 2
Testing a new combination therapy for liver cancer
This trial tests a new drug, RZ-001, combined with valganciclovir, atezolizumab, and bevacizumab for people with hepatocellular carcinoma (a type of liver cancer). The goal is to see if this combination is safe and works better than current treatments.
BusanAges 18 years+ - NCT06728098Recruiting
Testing safety of a gut-health probiotic in healthy adults
This trial is testing a new probiotic called Akkermansia muciniphila in healthy adults. It aims to see if the supplement is safe and well-tolerated, possibly helping with gut health.
Jakarta Pusat, Jakarta Special Capital RegionAges 18–60
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.